Sex differences in the molecular mechanisms of blood pressure control suggest that a one-size-fits-all approach to treating hypertension is outdated and sex-specific therapies may be required.
Are there sex differences in the molecular mechanisms of blood pressure control in hypertension?
This review emphasizes the importance of considering sex differences in the molecular mechanisms of blood pressure control for hypertension management.
Hypertension is a complex and multifaceted disease, and there are well established sex differences in many aspects of blood pressure (BP) control. The intent of this review is to highlight recent work examining sex differences in the molecular mechanisms of BP control in hypertension to assess whether the "one-size-fits-all" approach to BP control is appropriate with regard to sex.
Zimmerman et al. (Mon,) conducted a review in Hypertension. Sex differences in the molecular mechanisms of blood pressure control suggest that a one-size-fits-all approach to treating hypertension is outdated and sex-specific therapies may be required.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: